stopper_trace
TL2 Member · Jönköping, SE
Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.
Joined 24 March 2025 · last posted 2d
86 posts, newest first. Showing up to 150.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #60 · Clinical › Comorbidities · 26 Jul 2026 · 17 likes Everything in post #58 holds. The case it does not cover is the one I have. I would keep PCOS and metabolic overlap and the decision it usually gets used for separate…
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #9 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 30 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #65 · Compounds › Repair & healing peptides · 23 Jul 2026 · 0 likes Narrowing post #62, because the general version has more than one answer. Stability of BPC-157 in solution: what has been measured in published work covers specific…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #37 · Compounds › Retatrutide · 17 Jul 2026 · 0 likes Summarising the glucagon receptor agonist thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #47 · Practice › Administration · 15 Jul 2026 · 14 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
How shortages have affected compounding permissions Replied, post #37 · Access › Shortages · 14 Jul 2026 · 0 likes Post #36 is right about the mechanism and I think understates the practical bit. Shortage status determines what compounding is permitted in some jurisdictions, which…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #52 · Clinical › Comorbidities · 13 Jul 2026 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
-
Follow-up: Reading an interaction checker output critically Replied, post #44 · Practice › Interactions · 13 Jul 2026 · 0 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
Journal club: what we got wrong in an earlier session Replied, post #75 · Evidence › Journal club · 12 Jul 2026 · 10 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Spreadsheets: an appreciation — what changed since Replied, post #96 · Lounge › Off topic · 10 Jul 2026 · 11 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #66 · Analytics › Home & field testing · 6 Jul 2026 · 0 likes Reflectance and photometric devices is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #59 · Access › International · 5 Jul 2026 · 0 likes That is a cleaner way of putting what I was circling around.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #52 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 31 likes Post #50 and I disagree about the size of the effect, not about the direction. Where the baseline is drawn is the least documented and most consequential choice in the…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #76 · Start Here › Welcome · 16 Jun 2026 · 2 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #18 · Practice › Dosing & titration · 4 Jun 2026 · 1 like That matches what I have seen, for whatever a single anecdote is worth.
-
What I would want from a home test that does not exist yet Replied, post #3 · Analytics › Home & field testing · 3 Jun 2026 · 33 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #45 · Practice › Storage & stability · 1 Jun 2026 · 2 likes What I would want before treating Mean kinetic temperature as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three…
-
Shoulders, tangent skims, and defensible integration Replied, post #4 · Analytics › HPLC & UHPLC · 27 May 2026 · 30 likes A shoulder on the trailing edge is most often a closely related species rather than an artefact. The way to find out is to change the gradient slope, not to argue about…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #14 · Compounds › Secretagogues & GH axis · 27 May 2026 · 7 likes Counterpoint on secretagogues and glucose tolerance, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #58 · Practice › Reconstitution · 25 May 2026 · 1 like Post #56 and I disagree about the size of the effect, not about the direction. Two people can reconstitute the same vial to different concentrations and both be right.…
-
Follow-up: Search filters: what is missing Replied, post #95 · Meta › Site feedback · 6 May 2026 · 19 likes Not a bug, but worth saying: the moderation log is paginated at twenty-five entries and there is no way to filter it by rule. Being able to read every R6 action in…
-
Why this subcategory is stricter about sourcing than most Replied, post #25 · Compounds › Secretagogues & GH axis · 2 May 2026 · 1 like Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #53 · Practice › Administration · 2 May 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #54 · Sourcing › Logistics · 28 Apr 2026 · 4 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. I have no interest in any…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #126 · Practice › Reconstitution · 26 Apr 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is all…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #154 · Access › Pricing · 21 Apr 2026 · 1 like Post #153 is right about the mechanism and I think understates the practical bit. Cost per milligram is the only comparison that survives format differences, but even…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #68 · Start Here › Welcome · 19 Apr 2026 · 26 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #30 · Practice › Reconstitution · 19 Apr 2026 · 3 likes Adding the measurement that post #29 says would settle it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #3 · Analytics › Mass spectrometry · 14 Apr 2026 · 16 likes Answering the question the opening post raises rather than the one it answers. 2 ppm match was covered in the wiki last year and the page has a review date on it, which…
-
Bioimpedance and hydration: why the number moves Replied, post #21 · Outcomes › Body composition · 23 Mar 2026 · 32 likes Coming back to post #20, because the follow-up matters more than the original answer. My position on bioimpedance and hydration is current rather than settled. I have…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #53 · Data & Tools › Calculators · 21 Feb 2026 · 10 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #14 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes On mass error in ppm, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #44 · Research Methods › N-of-1 designs · 9 Feb 2026 · 3 likes Narrowing post #41, because the general version has more than one answer. A rolling mean over several days is far more informative than any single reading for anything…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #61 · Start Here › How to Ask · 8 Feb 2026 · 12 likes Post #59 describes the usual case. This is about the unusual one. The specific question in the title is more useful than you might think. A title like "a question I…
-
When to stop reading forums, including this one Replied, post #71 · Wellbeing › Mental health · 4 Jan 2026 · 5 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well.
-
Moderation log format change Replied, post #16 · Meta › Announcements · 22 Dec 2025 · 29 likes Post #13 is the version of this I will quote in future. One addition. One more thing on moderation log format change that took me far too long to see: the two figures…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #10 · Practice › Reconstitution · 18 Dec 2025 · 0 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. The best check on any reconstitution calculation is to do it twice by two different…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #101 · Compounds › Other compounds · 26 Nov 2025 · 5 likes Answering the Sequence verification question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
-
Persistent vomiting and the threshold for seeking help Replied, post #75 · Safety › Adverse events · 24 Nov 2025 · 24 likes Everything in post #73 holds. The case it does not cover is the one I have. Nothing here is medical advice, and in this subcategory the phrase is doing more work than…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #49 · Compounds › Other compounds · 24 Nov 2025 · 13 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #20 · Clinical › Bloodwork · 6 Nov 2025 · 3 likes Adding what did not work for me on single out-of-range value, since the failures never get written up and they are half the useful information.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #36 · Clinical › Special populations · 15 Oct 2025 · 32 likes I read post #33 twice before replying, because I had assumed the opposite. Older adults: I would want to see the raw numbers rather than the summary before agreeing.…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #18 · Analytics › Method validation · 10 Oct 2025 · 1 like Adding the measurement that post #15 says would settle it. I think the Robustness question is answerable and has not been answered, which is a more optimistic position…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #18 · Evidence › Journal club · 6 Sep 2025 · 0 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. Step-hfpef and symptom endpoints: I would want to see the raw numbers rather than…
-
Are there stupid questions here? A staff answer, at length Replied, post #125 · Start Here › Welcome · 29 Aug 2025 · 2 likes Nobody is going to check your credentials and nobody is going to ask. What gets asked for is the basis of a claim, which is a different thing and applies equally to…
-
Insurance and replacement policies, compared — the long version Replied, post #8 · Sourcing › Logistics · 22 Aug 2025 · 0 likes Where the Insurance and replacement policies discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #45 · Practice › Reconstitution · 20 Aug 2025 · 0 likes Decimal-point error has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #6 · Analytics › Method validation · 19 Aug 2025 · 6 likes On post #2 — agreed on the reasoning, with one qualification. My position on LOD and LOQ is current rather than settled. I have revised it once already and I expect to…
-
Asking about a compound your prescriber has not heard of Replied, post #129 · Clinical › Prescriber conversations · 17 Aug 2025 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Adding the caveat now so it…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #61 · Compounds › Secretagogues & GH axis · 13 Aug 2025 · 25 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #14 · Sourcing › Red flags · 31 Jul 2025 · 8 likes Coming back to post #10, because the follow-up matters more than the original answer. The guidelines draw that line for a practical reason as much as a fair one:…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #94 · Compounds › Semaglutide · 30 Jul 2025 · 31 likes Post #93 put the caveat in the right place and I want to underline it. Checked the Semaglutide half-life claim against the primary source this morning. It survives,…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #48 · Sourcing › Regulatory · 12 Jul 2025 · 10 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #66 · Compounds › Repair & healing peptides · 12 Jul 2025 · 0 likes Picking up post #65: that is the part I would want checked first. On TB-500 and thymosin beta-4 I would separate what is worth knowing from what is worth acting on. The…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #42 · Devices › Cold chain · 23 Jun 2025 · 0 likes A note on scope: what I am saying about Airline travel applies to the case in the first post and I would not extend it further without checking.
-
Half-life, steady state, and accumulation worked through Replied, post #93 · Pharmacology › Pharmacokinetics · 10 Jun 2025 · 24 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Half-life, steady state, and accumulation worked through Replied, post #78 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Subcutaneous absorption is the rate-limiting step for most of these compounds,…
-
Triple agonism: additive, synergistic, or neither? Replied, post #54 · Compounds › Retatrutide · 7 Jun 2025 · 0 likes Whether triple agonism is additive or synergistic is an open question and the published work does not answer it. A phase 2 trial without a dual-agonist comparator arm…
-
A claim built entirely on a subgroup analysis Replied, post #79 · Evidence › Study critique · 6 Jun 2025 · 27 likes This follows post #76 rather than contradicting it. Placebo-controlled versus active-controlled changes what a result means entirely, and comparing across the two is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #126 · Practice › Reconstitution · 5 Jun 2025 · 13 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
-
Pregnancy as an absolute contraindication Replied, post #87 · Safety › Contraindications · 20 May 2025 · 8 likes Coming back to post #85, because the follow-up matters more than the original answer. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires…
-
Transit times by route, from a logged dataset — the long version Replied, post #86 · Sourcing › Logistics · 25 Apr 2025 · 13 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. It is the sort of thing…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #21 · Clinical › Comorbidities · 21 Apr 2025 · 5 likes Careful with the language on Cardiovascular risk. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
A supplier that answers analytical questions with restated claims Replied, post #42 · Sourcing › Red flags · 19 Mar 2025 · 0 likes I read post #40 twice before replying, because I had assumed the opposite. The strongest single signal available cheaply is what happens when you ask a technical…
-
Antibiotics and a course of something with delayed emptying Replied, post #2 · Practice › Interactions · 9 Mar 2025 · 31 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #54 · Analytics › COA interpretation · 6 Mar 2025 · 2 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #162 · Sourcing › Regulatory · 6 Mar 2025 · 22 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. I have…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #33 · Documentation › Doc review · 23 Feb 2025 · 20 likes Reading this draft on reconstitution arithmetic thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #88 · Data & Tools › Calculators · 13 Feb 2025 · 8 likes Post #86 is the version of this I will quote in future. One addition. Mass error checking: enter your observed mass and theoretical mass and check whether the…
-
Canadian access and provincial variation Replied, post #76 · Regional › North America · 10 Feb 2025 · 20 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Preservatives: function, testing, and limits Replied, post #5 · Pharmacology › Formulation chemistry · 26 Jan 2025 · 13 likes I keep a log for preservatives specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 23 Jan 2025 · 16 likes Answering the question post #19 raises rather than the one it answers. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #17 · Analytics › Mass spectrometry · 2 Jan 2025 · 3 likes Thank you for the correction. I would rather find out here than later.
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #3 · Data & Tools › Calculators · 22 Dec 2024 · 3 likes The most useful thing anyone has posted about feature request in this category was a table of what had been measured and by whom. That is what I would want again.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #45 · Sourcing › Regulatory · 16 Dec 2024 · 29 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. Take it as a starting…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #9 · Devices › Cold chain · 13 Nov 2024 · 1 like That is consistent with mine, for whatever one more account is worth.
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #49 · Clinical › Prescriber conversations · 10 Nov 2024 · 8 likes The most useful question anyone here has reported asking: what would make you change your mind about this? Noting that the question and the thing people usually mean by…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #20 · Practice › Interactions · 25 Oct 2024 · 0 likes The honest answer on Grapefruit is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #71 · Clinical › Bloodwork · 1 Oct 2024 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #36 · Compounds › Retatrutide · 14 Sep 2024 · 11 likes The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat oxidation in the liver. Mechanistic plausibility in this field has a poor…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #8 · Clinical › Special populations · 30 Aug 2024 · 0 likes Picking up post #5: that is the part I would want checked first. The most useful contribution here is usually a citation to whichever published document comes closest,…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #21 · Analytics › Method validation · 24 Aug 2024 · 4 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Correlation in a self-tracked dataset: what it can support Replied, post #24 · Research Methods › Statistics · 21 Aug 2024 · 1 like Nothing to add on the substance. Thank you for taking the question at face value.
-
Pen wastage and its effect on real cost Replied, post #8 · Access › Pricing · 16 Jul 2024 · 1 like Cost per milligram is the only comparison that survives format differences, and even then it needs care.
-
Follow-up: Dead volume across syringe and needle combinations Started this topic · Devices › Syringes & needles · 13 Jun 2024 · 0 likes Dead volume across syringe and needle combinations — setting out what I have, and where I think it stops being reliable. A follow-up question about Dead volume across…
-
Assessing a warm arrival: the decision process — one year on Replied, post #137 · Sourcing › Logistics · 2 Jun 2024 · 9 likes Post #135 put the caveat in the right place and I want to underline it. Adding a small correction to the Assessing a warm arrival summary above rather than a…